This website is not intended for the visitors from France or the USA. If you are a healthcare professional in these regions, please use the region switcher above to change region.

User Login

Our core expertise lies in Self-Assembling Peptide-based hydrogels for haemostasis.

PuraStat has been used as a haemostatic agent for over 10 years across a wide range of clinical indications, including gastrointestinal, cardiovascular, and solid organ procedures, in Europe, the US, Australia, and Asia (Japan).

Leveraging our extensive experience and network of clinicians, researchers, and sales professionals, we are now focusing on expanding the indications for our products. As per our strong background in GI, we aim to further develop the use of peptides in areas such as GI mucosal healing and IBD. Additional ongoing developments include:

  • Prevention of delayed bleeding and adhesion reduction, particularly in ENT procedures
  • Neurological haemostasis for brain and spine surgeries
  • Extending the use of our products to the paediatric population

With a team of skilled experts in research, clinical practice, quality assurance, and regulatory affairs, we are well-equipped to conduct clinical research and design control activities.